Anterogen Co (XKRX:065660) Marketable Securities : ₩38,942 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Anterogen Co's Marketable Securities for the quarter that ended in Mar. 2024 was ₩38,942 Mil.

Anterogen Co's annual Marketable Securities increased from Dec. 2021 (₩50,715 Mil) to Dec. 2022 (₩52,065 Mil) but then declined from Dec. 2022 (₩52,065 Mil) to Dec. 2023 (₩48,945 Mil).

Anterogen Co Marketable Securities Historical Data

The historical data trend for Anterogen Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Marketable Securities Chart

Anterogen Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

7,954.92

39,442.41

50,715.50

52,065.37

48,945.03

Anterogen Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															53,713.11	47,795.43	47,603.38	48,945.03	38,941.82

Anterogen Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Anterogen Co (XKRX:065660) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Anterogen Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Anterogen Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anterogen Co (XKRX:065660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines